Literature DB >> 9283718

The involvement of tumour necrosis factor-alpha in the protective effects of 17 beta oestradiol in splanchnic ischaemia-reperfusion injury.

F Squadrito1, D Altavilla, G Squadrito, G M Campo, M Arlotta, V Arcoraci, L Minutoli, A Saitta, A P Caputi.   

Abstract

1. Tumour necrosis factor-alpha (TNF-alpha) is a cytokine that is implicated in the pathogenesis of ischaemic states and atherosclerosis. We tested the hypothesis that the vasoprotective effects of the oestrogens may be mediated in vivo by inhibition of the formation of TNF-alpha. 2. Anaesthetized rats, subjected to total occlusion of the superior mesenteric artery and the coeliac trunk for 45 min developed a severe shock state resulting in a fatal outcome within 75-90 min after the release of occlusion. Sham-operated animals were used as controls. 3. Splanchnic artery occlusion (SAO) shocked rats had a marked hypotension, enhanced levels of TNF-alpha in serum and macrophages, leukopenia and increased ileal leukocyte accumulation, studied by means of myeloperoxidase activity (MPO). Furthermore, aortae from SAO rats showed a marked hyporeactivity to phenylephrine (PE, 1 nM-10 microM), reduced responsiveness to acetylcholine (ACh, 10 nM-10 microM) and an increased staining for intercellular adhesion molecule-1 (ICAM-1). 4. In vivo administration of 17 beta oestradiol (500 micrograms kg-1, i.m., three hours before the induction of SAO) increased survival rate (100%, 4 h after SAO), enhanced mean arterial blood pressure; reduced serum TNF-alpha (25 +/- 5 u ml-1 vs 379 +/- 16 u ml-1), ameliorated leukopaenia and reduced ileal MPO (0.7 +/- 0.02 u 10(-3) g-1 tissue vs 4.2 +/- 0.4 u 10(-3) g-1 tissue). Furthermore aortae from SAO rats treated with 17 beta oestradiol exhibited a greater contractile response to phenylephrine, improved responsiveness to ACh and a blunted staining of ICAM-1. Finally 17 beta oestradiol, added in vitro to peritoneal macrophages collected from untreated SAO rats, significantly reduced TNF-alpha production. 5. Our results suggest that inhibition of TNF-alpha in vivo may explain, at least in part, the vasoprotective effects of oestrogens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9283718      PMCID: PMC1564848          DOI: 10.1038/sj.bjp.0701288

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  6 in total

1.  Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemia.

Authors:  Xiaofeng Sun; Masato Imai; Martina Nowak-Machen; Olaf Guckelberger; Keiichi Enjyoji; Yan Wu; Zain Khalpey; Pascal Berberat; Jeeva Munasinghe; Simon Christopher Robson
Journal:  Purinergic Signal       Date:  2011-06-09       Impact factor: 3.765

2.  The role of 17-beta estradiol in ischemic preconditioning protection of the heart.

Authors:  Fawzi A Babiker; Lamia J Hoteit; Shaji Joseph; Abu Salim Mustafa; Jasbir S Juggi
Journal:  Exp Clin Cardiol       Date:  2012-09

3.  Effects of High Estrogen Levels on Monocyte Chemoattractant Protein-1 and Wound Healing.

Authors:  Timothy P Plackett; Meredith S Gregory; Elizabeth J Kovacs
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-02-01       Impact factor: 4.730

4.  Estradiol treatment ameliorates acetic acid-induced gastric and colonic injuries in rats.

Authors:  Omer Günal; Berna K Oktar; Emine Ozçinar; Mustafa Sungur; Serap Arbak; Berrak Yeğen
Journal:  Inflammation       Date:  2003-12       Impact factor: 4.092

5.  Role of endogenous vitamin E in renal ischemic preconditioning process: differences between male and female rats.

Authors:  Simin Aryamanesh; Seyyed Meisam Ebrahimi; Nahid Abotaleb; Maliheh Nobakht; Parvaneh Rahimi-Moghaddam
Journal:  Iran Biomed J       Date:  2012

6.  Sex differences in inflammatory cytokine production in hepatic ischemia-reperfusion.

Authors:  Elahé T Crockett; William Spielman; Shadi Dowlatshahi; Jun He
Journal:  J Inflamm (Lond)       Date:  2006-12-19       Impact factor: 4.981

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.